Sanford C. Bernstein Begins Coverage on Daiichi Sankyo (OTCMKTS:DSNKY)

Sanford C. Bernstein initiated coverage on shares of Daiichi Sankyo (OTCMKTS:DSNKYGet Rating) in a research note released on Tuesday morning, The Fly reports. The brokerage issued an underperform rating on the stock.

Daiichi Sankyo Trading Down 3.4 %

Shares of OTCMKTS DSNKY opened at $33.07 on Tuesday. The firm’s 50-day moving average price is $35.03 and its 200-day moving average price is $33.23. Daiichi Sankyo has a 1-year low of $22.50 and a 1-year high of $36.66.

Daiichi Sankyo Company Profile

(Get Rating)

Daiichi Sankyo Co, Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.

Further Reading

The Fly logo

Receive News & Ratings for Daiichi Sankyo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Daiichi Sankyo and related companies with's FREE daily email newsletter.